Healthcare -
Biotechnology - NASDAQ - US
$ 8.5847
8.67 %
$ 425 M
Market Cap
-1.71
P/E
RGNX - DEFERRED INCOME TAX
Deferred Income Tax RGNX - REGENXBIO Inc.
0
LAST VALUE
41.42%
2 YEAR CAGR
0.00%
5 YEAR CAGR
0.00%
10 YEAR CAGR